In patients with heart failure and iron deficiency, ferric carboxymaltose did not significantly reduce the time to first heart failure hospitalization or cardiovascular death in the overall cohort or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback